Top Markets
Coin of the day
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Rang in aandelen #6654
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Aandeelprijs
$6.02
Laatst gesynchroniseerd: 2026-08-27
Marktkapitalisatie
$1.93B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
112.72%
Land
US
Handel Taysha Gene Therapies, Inc. (TSHA)

Categorie

Koersgeschiedenis voor Taysha Gene Therapies, Inc. (TSHA)
Hoogste slotkoers: $6.22 op 2026-08-01

Laagste slotkoers: $23.52 op 2020-09-01
Koersgeschiedenis van Taysha Gene Therapies, Inc. van 2020 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -5.89%
2025 151.61%
2024 28.42%
2023 -21.84%
2022 -83.88%
2021 -42.11%
2020 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$548.36 39.87%
US
$1.06K 50.29%
NL
$122.42 -11.85%
AU
$140.81 475.44%
US
$765.25 7.74%
CH